4XG-10861-48038
5 vaccinations
5 coded responses
29 check-ins
4 free-text entries
4 call cases
- Sex
- Female
- Age at first dose
- 46-50
- ZIP prefix
- 281 / NC
- Registered
- 2021-03-11
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-11
Registered in v-safe
-
2021-03-11
Dose 1 — Pfizer-BioNTech
- 2021-03-11
- 2021-03-12
-
2021-03-13
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Headache, Fatigue or tiredness, Nausea, Abdominal painAdult check-in
-
2021-03-14
Health check-in — days 1–6 daily, dose 1Feeling: Good · Fatigue or tiredness, NauseaAdult check-in
- 2021-03-16
- 2021-03-17
- 2021-03-18
-
2021-03-25
Survey response — day 14, dose 1MedDRA: Pyrexia — Feeling: GoodFree text: Slightly feverish but low gradeMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-01
Dose 2 — Pfizer-BioNTech
-
2021-04-02
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-04-03
- 2021-04-05
- 2021-04-07
- 2021-04-08
- 2021-04-17
- 2021-04-22
- 2021-04-29
- 2021-05-06
- 2021-05-13
- 2021-07-01
-
2021-09-04
Dose 3 — Pfizer-BioNTechCo-administered: Flu
- 2021-09-30
- 2022-04-02
-
2022-05-30
Dose 4 — Pfizer-BioNTech
-
2022-09-13
Dose 5 — Pfizer-BioNTechCo-administered: Flu
-
2022-09-20
Health check-in — day 7, dose 5Feeling: Fair · Muscle or body aches, Fatigue or tirednessAdult check-in
-
2022-09-27
Survey response — day 14, dose 5MedDRA: Heart rate increased, Influenza like illness — Feeling: Fair · Be unable to work or attend school, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Flu-like symptoms, racing heart rateMedDRA releases: 2024-11 · check-in free text available
-
2022-09-27
Report sent to call center — day 14, dose 5Be unable to work or attend school · Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2022-09-29
- 2022-10-04
- 2022-10-11
-
2022-10-18
Survey response — day 35, dose 5MedDRA: Dizziness, Hypertension, Palpitations — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Heart palpitations, high blood pressure, dizziness.MedDRA releases: 2024-11 · check-in free text available
-
2022-10-18
Report sent to call center — day 35, dose 5Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2022-10-19
- 2022-10-19
- 2022-10-25
-
2022-12-14
Survey response — 3 months, dose 5MedDRA: Malaise, Post-acute COVID-19 syndrome — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visitFree text: Long Covid with PEMMedDRA releases: 2024-11 · check-in free text available
-
2022-12-14
Report sent to call center — 3 months, dose 5Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-12-15
- 2022-12-15
- 2022-12-16
- 2022-12-16
- 2022-12-16
-
2023-03-14
Survey response — 6 months, dose 5MedDRA: Mast cell activation syndrome — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationMedDRA releases: 2024-11
-
2023-03-14
Report sent to call center — 6 months, dose 5Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2023-03-15
- 2023-03-15
- 2023-03-15
- 2023-03-15
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-11 | Pfizer-BioNTech | |
| 2 | 2021-04-01 | Pfizer-BioNTech | |
| 3 | 2021-09-04 | Pfizer-BioNTech | Flu |
| 4 | 2022-05-30 | Pfizer-BioNTech | No |
| 5 | 2022-09-13 | Pfizer-BioNTech | Flu |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-09-27 | Unsuccessful | |
| 2022-10-18 | Unsuccessful | |
| 2022-12-14 | Unsuccessful | |
| 2023-03-14 | Unsuccessful |
Free text
Release 6 — day 14, dose 1
Symptoms: Slightly feverish but low grade
Release 12 — day 14, dose 5
Symptoms: Flu-like symptoms, racing heart rate
Release 12 — day 35, dose 5
Symptoms: Heart palpitations, high blood pressure, dizziness.
Release 12 — 3 months, dose 5
Symptoms: Long Covid with PEM
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Dizziness | · | · | ✓ |
| SD | Heart rate increased | · | · | ✓ |
| SD | Hypertension | · | · | ✓ |
| SD | Influenza like illness | · | · | ✓ |
| SD | Malaise | · | · | ✓ |
| SD | Mast cell activation syndrome | · | · | ✓ |
| SD | Palpitations | · | · | ✓ |
| SD | Post-acute COVID-19 syndrome | · | · | ✓ |
| SD | Pyrexia | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release